Global Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Region: Trend Forecast and Growth Opportunity

October 2020 | 173 pages | ID: GB80BCA68BF8EN
GMD Research

Abstracts

Global pharmaceutical contract manufacturing market will reach $184.8 billion by 2030, growing by 6.2% annually over 2020-2030 driven by increasing dependence on contract manufacturing organizations due to improved efficiency and productivity amid COVID-19 pandemic.

Highlighted with 87 tables and 85 figures, this 173-page report “Global Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical contract manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical contract manufacturing market in every aspect of the classification from perspectives of Category, Product, Phase, Type, Therapeutic Application, and Region.

Based on Category, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Pharmaceutical Industry
• Biopharmaceutical Industry

Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Active Pharmaceutical Ingredients (API)

• Branded API Manufacturing
• Generic API Manufacturing

Finished Dosage Formulations (FDF)

• Solid Dosage
• Oral Liquids
• Parenteral/Injectables
• Other FDFs

Secondary Packaging

Based on Phase, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Clinical Manufacturing
• Commercial Manufacturing

Based on Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Sterile Products
• Non-Sterile Products

Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Phase, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global pharmaceutical contract manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
Aenova Group
Baxter BioPharma Solutions
Boehringer Ingelheim
Catalent Inc.
Famar S.A.
Hospira, Inc.
Jubilant Life Sciences Ltd.
Lonza Group
Patheon Inc.
Pfizer CentreSource
Recipharm AB
Vetter Pharma International GmbH

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY CATEGORY

3.1 Market Overview by Category
3.2 Pharmaceutical Industry
3.3 Biopharmaceutical Industry

4 SEGMENTATION OF GLOBAL MARKET BY PRODUCT

4.1 Market Overview by Product
4.2 Active Pharmaceutical Ingredients (API)
  4.2.1 Branded API Manufacturing
  4.2.2 Generic API Manufacturing
4.3 Finished Dosage Formulations (FDF)
  4.3.1 Solid Dosage
  4.3.2 Oral Liquids
  4.3.3 Parenteral/Injectables
  4.3.4 Other FDFs
4.4 Secondary Packaging

5 SEGMENTATION OF GLOBAL MARKET BY PHASE

5.1 Market Overview by Phase
5.2 Clinical Manufacturing
5.3 Commercial Manufacturing

6 SEGMENTATION OF GLOBAL MARKET BY TYPE

6.1 Market Overview by Type
6.2 Sterile Products
6.3 Non-Sterile Products

7 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC APPLICATION

7.1 Market Overview by Therapeutic Application
7.2 Infectious Diseases
7.3 Oncology
7.4 Metabolic Disorders
7.5 Cardiovascular Disorders
7.6 Central Nervous System
7.7 Pulmonary Disorders
7.8 Gastrointestinal Disorders
7.9 Other Therapeutic Applications

8 SEGMENTATION OF GLOBAL MARKET BY REGION

8.1 Geographic Market Overview 2019-2030
8.2 North America Market 2019-2030 by Country
  8.2.1 Overview of North America Market
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 European Market 2019-2030 by Country
  8.3.1 Overview of European Market
  8.3.2 Germany
  8.3.3 UK
  8.3.4 France
  8.3.5 Spain
  8.3.6 Italy
  8.3.7 Russia
  8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2019-2030 by Country
  8.4.1 Overview of Asia-Pacific Market
  8.4.2 Japan
  8.4.3 China
  8.4.4 Australia
  8.4.5 India
  8.4.6 South Korea
  8.4.7 Rest of APAC Region
8.5 South America Market 2019-2030 by Country
  8.5.1 Argentina
  8.5.2 Brazil
  8.5.3 Chile
  8.5.4 Rest of South America Market
8.6 MEA Market 2019-2030 by Country
  8.6.1 UAE
  8.6.2 Saudi Arabia
  8.6.3 South Africa
  8.6.4 Other National Markets

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Aenova Group
Baxter BioPharma Solutions
Boehringer Ingelheim
Catalent Inc.
Famar S.A.
Hospira, Inc.
Jubilant Life Sciences Ltd.
Lonza Group
Patheon Inc.
Pfizer CentreSource
Recipharm AB
Vetter Pharma International GmbH

10 INVESTING IN GLOBAL MARKET: RISK ASSESSMENT AND MANAGEMENT

10.1 Risk Evaluation of Global Market
10.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Pharmaceutical Contract Manufacturing Market, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Market Opportunities in Global Pharmaceutical Contract Manufacturing Market
Table 4. Global Pharmaceutical Contract Manufacturing Market by Category, 2019-2030, $ bn
Table 5. Global Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 6. Global Pharmaceutical Contract Manufacturing Market: Active Pharmaceutical Ingredients (API) by Type, 2019-2030, $ bn
Table 7. Global Pharmaceutical Contract Manufacturing Market: Finished Dosage Formulations (FDF) by Type, 2019-2030, $ bn
Table 8. Global Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 9. Global Pharmaceutical Contract Manufacturing Market by Type, 2019-2030, $ bn
Table 10. Global Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 11. Global Pharmaceutical Contract Manufacturing Market by Region, 2019-2030, $ bn
Table 12. Leading National Pharmaceutical Contract Manufacturing Market, 2019 and 2030, $ bn
Table 13. North America Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn
Table 14. U.S. Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 15. U.S. Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 16. U.S. Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 17. Canada Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 18. Canada Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 19. Canada Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 20. Mexico Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 21. Mexico Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 22. Mexico Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 23. Europe Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn
Table 24. Germany Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 25. Germany Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 26. Germany Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 27. UK Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 28. UK Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 29. UK Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 30. France Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 31. France Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 32. France Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 33. Spain Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 34. Spain Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 35. Spain Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 36. Italy Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 37. Italy Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 38. Italy Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 39. Russia Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 40. Russia Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 41. Russia Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 42. Pharmaceutical Contract Manufacturing Market in Rest of Europe by Country, 2019-2030, $ bn
Table 43. APAC Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn
Table 44. Japan Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 45. Japan Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 46. Japan Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 47. China Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 48. China Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 49. China Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 50. Australia Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 51. Australia Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 52. Australia Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 53. India Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 54. India Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 55. India Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 56. South Korea Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 57. South Korea Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 58. South Korea Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 59. Pharmaceutical Contract Manufacturing Market in Rest of APAC by Country, 2019-2030, $ bn
Table 60. South America Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn
Table 61. Argentina Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 62. Argentina Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 63. Argentina Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 64. Brazil Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 65. Brazil Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 66. Brazil Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 67. Chile Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 68. Chile Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 69. Chile Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 70. MEA Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn
Table 71. UAE Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 72. UAE Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 73. UAE Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 74. Saudi Arabia Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 75. Saudi Arabia Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 76. Saudi Arabia Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 77. South Africa Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn
Table 78. U.S. Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn
Table 79. U.S. Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn
Table 80. Breakdown of Global Market by Key Vendor, 2019, %
Table 81. Aenova Group: Company Snapshot
Table 82. Aenova Group: Business Segmentation
Table 83. Aenova Group: Product Portfolio
Table 84. Aenova Group: Revenue, 2016-2018, $ bn
Table 85. Aenova Group: Recent Developments
Table 86. Risk Evaluation for Investing in Global Market, 2019-2030
Table 87. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Global Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical Contract Manufacturing Market
Figure 8. Primary Restraints and Impact Factors of Global Pharmaceutical Contract Manufacturing Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Global Pharmaceutical Contract Manufacturing Market
Figure 11. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Category, 2019-2030, % of Revenue
Figure 12. Global Addressable Market Cap in 2020-2030 by Category, Value ($ bn) and Share (%)
Figure 13. Global Pharmaceutical Contract Manufacturing Market: Pharmaceutical Industry, 2019-2030, $ bn
Figure 14. Global Pharmaceutical Contract Manufacturing Market: Biopharmaceutical Industry, 2019-2030, $ bn
Figure 15. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, % of Sales Revenue
Figure 16. Global Addressable Market Cap in 2020-2030 by Product, Value ($ bn) and Share (%)
Figure 17. Global Pharmaceutical Contract Manufacturing Market: Active Pharmaceutical Ingredients (API), 2019-2030, $ bn
Figure 18. Global Pharmaceutical Contract Manufacturing Market: Branded API Manufacturing, 2019-2030, $ bn
Figure 19. Global Pharmaceutical Contract Manufacturing Market: Generic API Manufacturing, 2019-2030, $ bn
Figure 20. Global Pharmaceutical Contract Manufacturing Market: Finished Dosage Formulations (FDF), 2019-2030, $ bn
Figure 21. Global Pharmaceutical Contract Manufacturing Market: Solid Dosage, 2019-2030, $ bn
Figure 22. Global Pharmaceutical Contract Manufacturing Market: Oral Liquids, 2019-2030, $ bn
Figure 23. Global Pharmaceutical Contract Manufacturing Market: Parenteral/Injectables, 2019-2030, $ bn
Figure 24. Global Pharmaceutical Contract Manufacturing Market: Other FDFs, 2019-2030, $ bn
Figure 25. Global Pharmaceutical Contract Manufacturing Market: Secondary Packaging, 2019-2030, $ bn
Figure 26. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, % of Sales Revenue
Figure 27. Global Addressable Market Cap in 2020-2030 by Phase, Value ($ bn) and Share (%)
Figure 28. Global Pharmaceutical Contract Manufacturing Market: Clinical Manufacturing, 2019-2030, $ bn
Figure 29. Global Pharmaceutical Contract Manufacturing Market: Commercial Manufacturing, 2019-2030, $ bn
Figure 30. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Type, 2019-2030, % of Revenue
Figure 31. Global Addressable Market Cap in 2020-2030 by Type, Value ($ bn) and Share (%)
Figure 32. Global Pharmaceutical Contract Manufacturing Market: Sterile Products, 2019-2030, $ bn
Figure 33. Global Pharmaceutical Contract Manufacturing Market: Non-Sterile Products, 2019-2030, $ bn
Figure 34. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, % of Revenue
Figure 35. Global Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%)
Figure 36. Global Pharmaceutical Contract Manufacturing Market: Infectious Diseases, 2019-2030, $ bn
Figure 37. Global Pharmaceutical Contract Manufacturing Market: Oncology, 2019-2030, $ bn
Figure 38. Global Pharmaceutical Contract Manufacturing Market: Metabolic Disorders, 2019-2030, $ bn
Figure 39. Global Pharmaceutical Contract Manufacturing Market: Cardiovascular Disorders, 2019-2030, $ bn
Figure 40. Global Pharmaceutical Contract Manufacturing Market: Central Nervous System, 2019-2030, $ bn
Figure 41. Global Pharmaceutical Contract Manufacturing Market: Pulmonary Disorders, 2019-2030, $ bn
Figure 42. Global Pharmaceutical Contract Manufacturing Market: Gastrointestinal Disorders, 2019-2030, $ bn
Figure 43. Global Pharmaceutical Contract Manufacturing Market: Other Therapeutic Applications, 2019-2030, $ bn
Figure 44. Global Market Snapshot by Region
Figure 45. Geographic Spread of Worldwide Pharmaceutical Contract Manufacturing Market, 2019-2030, % of Sales Revenue
Figure 46. Global Addressable Market Cap in 2020-2030 by Region, Value ($ bn) and Share (%)
Figure 47. North American Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn
Figure 48. Breakdown of North America Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 49. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 50. U.S. Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn
Figure 51. Canada Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn
Figure 52. Pharmaceutical Contract Manufacturing Market in Mexico, 2015-2030, $ bn
Figure 53. European Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn
Figure 54. Breakdown of European Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 55. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 56. Pharmaceutical Contract Manufacturing Market in Germany, 2019-2030, $ bn
Figure 57. Pharmaceutical Contract Manufacturing Market in UK, 2019-2030, $ bn
Figure 58. Pharmaceutical Contract Manufacturing Market in France, 2019-2030, $ bn
Figure 59. Pharmaceutical Contract Manufacturing Market in Spain, 2019-2030, $ bn
Figure 60. Pharmaceutical Contract Manufacturing Market in Italy, 2019-2030, $ bn
Figure 61. Pharmaceutical Contract Manufacturing Market in Russia, 2019-2030, $ bn
Figure 62. Pharmaceutical Contract Manufacturing Market in Rest of Europe, 2019-2030, $ bn
Figure 63. Asia-Pacific Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn
Figure 64. Breakdown of APAC Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 65. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 66. Pharmaceutical Contract Manufacturing Market in Japan, 2019-2030, $ bn
Figure 67. Pharmaceutical Contract Manufacturing Market in China, 2019-2030, $ bn
Figure 68. Pharmaceutical Contract Manufacturing Market in Australia, 2019-2030, $ bn
Figure 69. Pharmaceutical Contract Manufacturing Market in India, 2019-2030, $ bn
Figure 70. Pharmaceutical Contract Manufacturing Market in South Korea, 2019-2030, $ bn
Figure 71. Pharmaceutical Contract Manufacturing Market in Rest of APAC, 2019-2030, $ bn
Figure 72. South America Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn
Figure 73. Breakdown of South America Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 74. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 75. Pharmaceutical Contract Manufacturing Market in Argentina, 2019-2030, $ bn
Figure 76. Pharmaceutical Contract Manufacturing Market in Brazil, 2019-2030, $ bn
Figure 77. Pharmaceutical Contract Manufacturing Market in Chile, 2019-2030, $ bn
Figure 78. Pharmaceutical Contract Manufacturing Market in Rest of South America, 2019-2030, $ bn
Figure 79. Pharmaceutical Contract Manufacturing Market in Middle East and Africa (MEA), 2019-2030, $ bn
Figure 80. Breakdown of MEA Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 81. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 82. Pharmaceutical Contract Manufacturing Market in UAE, 2019-2030, $ bn
Figure 83. Pharmaceutical Contract Manufacturing Market in Saudi Arabia, 2019-2030, $ bn
Figure 84. Pharmaceutical Contract Manufacturing Market in South Africa, 2019-2030, $ bn
Figure 85. Growth Stage of Global Pharmaceutical Contract Manufacturing Industry over the Forecast Period